Dutch reimburse cervical cancer heat therapy:
This article was originally published in Clinica
The treatment of advanced cervical cancer using deep regional hyperthermia and radiation has been approved for reimbursement in the Netherlands. The Dutch parliament has also confirmed deep hyperthermia as the treatment of first choice for advanced cervical cancer. The move follows the positive outcome of a study on the heat therapy carried out at the University Medical School of Rotterdam. The clinical trial used the BSD-2000 system, developed by US company BSD Medical, to treat deep cervical tumours. Deep regional hyperthermia as an adjunct to cervical cancer treatment is already reimbursed in the German states of Bavaria, Berlin and Baden-Wurttemberg.
You may also be interested in...
An upturn in M&A activity across the whole healthcare sector is expected in 2021, with the COVID-19 pandemic and the associated development of a vaccine shining a light on the sector, says a recent survey by Jefferies.
Australian patients with phototoxicity due to the rare condition EPP will now have their first treatment option – provided the drug's developer, Clinuvel, secures reimbursement under the Pharmaceutical Benefits Scheme.
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.